+1 877 705 191424 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06004882

Peripheral Nerve Stimulation of Genicular Nerves Versus Conventional Therapy With Intra-articular Steroid Injection for Chronic Knee Pain A Prospective, Randomized Pilot Study

Led by M.D. Anderson Cancer Center · Updated on 2026-03-03

45

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating different therapies to improve knee range of motion in patients with chronic knee pain. The study compares a standard steroid injection, peripheral nerve stimulation PNS therapy combined with a steroid injection, and PNS therapy with a placebo injection. Steroid injections, containing triamcinolone and bupivacaine, are the usual treatment, and this study aims to explore the effects of adding PNS therapy alongside or instead of steroids. Participants are assigned to one of three groups one receiving a steroid injection only, another receiving PNS therapy along with a steroid injection, and the third receiving PNS therapy plus a placebo injection. PNS therapy involves implanting a small wire near the nerve causing pain, which is connected to an external device delivering electrical pulses for 60 days to block pain signals. The steroid injection is given directly into the knee joint. During the study, knee range of motion is measured using goniometry at baseline, 30, 60, and 90 days to assess changes. Researchers also track knee pain scores, use of opioids, and any complications or adverse effects. Safety is monitored through adverse event reporting averaged over one year. Participants are evaluated at multiple visits to monitor progress and outcomes throughout the study period.

CONDITIONS

Brief Title

Peripheral Nerve Stimulation of Genicular Nerves Versus Conventional Therapy With Intra-articular Steroid Injection for Chronic Knee Pain: A Prospective, Randomized Pilot Study

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients diagnosed with chronic knee pain with a baseline pain score of 4 or higher
  • Patients aged between 18 and 85 years old
  • Patients who have signed informed consent
  • If bilateral knee pain, the more severe side will be treated and counted toward study outcomes
Not Eligible

You will not qualify if you...

  • Patients with cognitive dysfunction or without capacity to consent
  • Patients with recent history (less than 6 months) of drug or alcohol abuse
  • Patients with open skin lesions or currently on antibiotics for local or systemic infection
  • Patients allergic to local anesthesia, steroids, or adhesives
  • Patients on opioids for reasons other than knee pain

Research Team

S

Saba Javed, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here